通过吸入性糖皮质激素治疗支气管哮喘分析其药理学特性  

Analysis of pharmacological properties of inhaled glucocorticoids in the treatment of bronchial asthma

作　　者：杨青青[1] 陆强[1] Yang Qingqing;Lu Qian(Department of Pharmacy,The Northern Jiangsu People's Hospital,Yangzhou,Jiangsu 225001,China)

机构地区：[1]江苏省苏北人民医院药学部,江苏扬州225001

出　　处：《医药前沿》2020年第7期20-22,共3页Journal of Frontiers of Medicine

摘　　要：支气管哮喘是临床上常见的一种呼吸系统疾病。目前吸入性糖皮质激素在治疗支气管哮喘中具有良好的治疗效果,且治疗安全性高,目前已成为控制支气管哮喘的一线药物。本文对吸入性糖皮质激素的药理学特性作如下分析。Bronchial asthma is a common clinical respiratory disease.At present,inhaled glucocorticoids have a certain effect in the treatment of bronchial asthma,and the treatment safety is relatively high.It has become the first-line drug for controlling bronchial asthma.This article analyzes the pharmacological properties of inhaled glucocorticoids as follows.

关 键 词：吸入性糖皮质激素 支气管哮喘 药理学特征 

分 类 号：R562[医药卫生—呼吸系统]